查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1487617

mRNA 疫苗市场（应用：Covid-19 等；最终用户：政府实体、私人医院和诊所等）- 2024-2034 年全球产业分析、规模、份额、成长、趋势和预测

mRNA Vaccine Market (Application: Covid-19, and Others; and End-user: Government Entities, Private Hospitals & Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 146 Pages | 商品交期: 2-10个工作天内

价格

mRNA 疫苗市场 - 报告范围

TMR 关于全球 mRNA 疫苗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 ，考虑2024年为基准年，2034年为预测年。报告中也提供了2024年至2034年全球mRNA疫苗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解 mRNA 疫苗市场。

市场概况
2023年市场价值 217 亿美元
2034 年市场价值 96 亿美元
复合年增长率 -4.3%

该报告深入探讨了全球 mRNA 疫苗市场的竞争格局。全球 mRNA 疫苗市场的主要参与者已经确定，并且每位参与者的不同属性都已被描述。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球 mRNA 疫苗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测
  • 波特五力分析

第 5 章：关键见解

  • 技术进步
  • 管道
  • 按地区/全球分類的监管情景
  • COVID-19大流行对该行业的影响分析

第 6 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按应用分類的市场价值预测
    • 新冠肺炎
    • 其他的
  • 按应用分類的市场吸引力

第 7 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年最终用户市场价值预测
    • 政府机构
    • 私立医院及诊所
    • 其他的
  • 最终用户的市场吸引力

第 8 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 9 章：北美市场分析与预测

  • 我们
  • 加拿大

第 10 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第 11 章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 12 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 13 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第14章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析 (2022)
  • 公司简介
    • Pfizer, Inc.
    • Moderna Inc.
    • Novartis AG
    • Sanofi
    • Arcturus Therapeutics
    • Gennova Biopharmaceuticals Ltd
    • Aimei Vaccine Co., Ltd
Product Code: TMRGL85998

mRNA Vaccine Market - Scope of Report

TMR's report on the global mRNA vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global mRNA vaccine market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mRNA vaccine market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the mRNA vaccine market.

Market Snapshot
Market Value in 2023US$ 21.7 Bn
Market Value in 2034US$ 9.6 Bn
CAGR-4.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mRNA vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mRNA vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mRNA vaccine market.

The report delves into the competitive landscape of the global mRNA vaccine market. Key players operating in the global mRNA vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mRNA vaccine market profiled in this report.

Key Questions Answered in Global mRNA vaccine Market Report:

  • What is the sales/revenue generated by mRNA vaccine across all regions during the forecast period?
  • What are the opportunities in the global mRNA vaccine market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

mRNA Vaccine Market - Research Objectives and Research Approach

The comprehensive report on the global mRNA vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global mRNA vaccine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mRNA vaccine market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global mRNA Vaccine Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global mRNA Vaccine Market Analysis and Forecasts, 2020-2034
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. mRNA Vaccines Pipeline
  • 5.3. Regulatory Scenario by Region/Globally
  • 5.4. COVID-19 Pandemic Impact Analysis on Industry

6. Global mRNA Vaccine Market Analysis and Forecasts, By Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Application, 2020-2034
    • 6.3.1. COVID-19
    • 6.3.2. Others
  • 6.4. Market Attractiveness By Application

7. Global mRNA Vaccine Market Analysis and Forecasts, By End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By End-user, 2020-2034
    • 7.3.1. Government Entities
    • 7.3.2. Private Hospitals & Clinics
    • 7.3.3. Others
  • 7.4. Market Attractiveness By End-user

8. Global mRNA Vaccine Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness By Country/Region

9. North America mRNA Vaccine Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Application, 2020-2034
    • 9.2.1. COVID-19
    • 9.2.2. Others
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Government Entities
    • 9.3.2. Private Hospitals & Clinics
    • 9.3.3. Others
  • 9.4. Market Value Forecast By Country, 2020-2034
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Application
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe mRNA Vaccine Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Application, 2020-2034
    • 10.2.1. COVID-19
    • 10.2.2. Others
  • 10.3. Market Value Forecast By End-user, 2020-2034
    • 10.3.1. Government Entities
    • 10.3.2. Private Hospitals & Clinics
    • 10.3.3. Others
  • 10.4. Market Value Forecast By Country, 2020-2034
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Application
    • 10.5.2. By End-user
    • 10.5.3. By Country

11. Asia Pacific mRNA Vaccine Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Application, 2020-2034
    • 11.2.1. COVID-19
    • 11.2.2. Others
  • 11.3. Market Value Forecast By End-user, 2020-2034
    • 11.3.1. Government Entities
    • 11.3.2. Private Hospitals & Clinics
    • 11.3.3. Others
  • 11.4. Market Value Forecast By Country, 2020-2034
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Application
    • 11.5.2. By End-user
    • 11.5.3. By Country

12. Latin America mRNA Vaccine Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Application, 2020-2034
    • 12.2.1. COVID-19
    • 12.2.2. Others
  • 12.3. Market Value Forecast By End-user, 2020-2034
    • 12.3.1. Government Entities
    • 12.3.2. Private Hospitals & Clinics
    • 12.3.3. Others
  • 12.4. Market Value Forecast By Country, 2020-2034
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Application
    • 12.5.2. By End-user
    • 12.5.3. By Country

13. Middle East & Africa mRNA Vaccine Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Application, 2020-2034
    • 13.2.1. COVID-19
    • 13.2.2. Others
  • 13.3. Market Value Forecast By End-user, 2020-2034
    • 13.3.1. Government Entities
    • 13.3.2. Private Hospitals & Clinics
    • 13.3.3. Others
  • 13.4. Market Value Forecast By Country, 2020-2034
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Application
    • 13.5.2. By End-user
    • 13.5.3. By Country

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Pfizer, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Moderna Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Novartis AG
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Sanofi
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Arcturus Therapeutics
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Gennova Biopharmaceuticals Ltd
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Aimei Vaccine Co., Ltd
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview

List of Tables

  • Table 01: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 02: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 03: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 04: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 05: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 06: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 07: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 08: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 09: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 10: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 11: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 12: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 13: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 15: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034
  • Table 16: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 18: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034

List of Figures

  • Figure 01: Global mRNA Vaccine Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global mRNA Vaccine Market Value Share, By Application, 2023
  • Figure 03: Global mRNA Vaccine Market Value Share, by End-User, 2023
  • Figure 04: Global mRNA Vaccine Market Value Share, by Region, 2023
  • Figure 05: Global mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 06: Global mRNA Vaccine Market Share Analysis, by Application, 2023
  • Figure 07: Global mRNA Vaccine Market Share Analysis, by Application, 2034
  • Figure 08: Global mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 09: Global mRNA Vaccine Market Value (US$ Mn), by COVID-19, 2020-2034
  • Figure 10: Global mRNA Vaccine Market Value Share Analysis, by COVID-19, 2023 and 2034
  • Figure 11: Global mRNA Vaccine Market Value (US$ Mn), by Others, 2020-2034
  • Figure 12: Global mRNA Vaccine Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 13: Global mRNA Vaccine Market Value (US$ Mn) Share Analysis, by End-User, 2023 and 2034
  • Figure 14: Global mRNA Vaccine Market Share Analysis, by End-User, 2023
  • Figure 15: Global mRNA Vaccine Market Share Analysis, by End-User, 2034
  • Figure 16: Global mRNA Vaccine Market Attractiveness Analysis, by End-User, 2024-2034
  • Figure 17: Global mRNA Vaccine Market Value (US$ Mn), by Government Entities, 2020-2034
  • Figure 18: Global mRNA Vaccine Market Value Share Analysis, by Government Entities, 2023 and 2034
  • Figure 19: Global mRNA Vaccine Market Value (US$ Mn), by Private Hospitals & Clinics, 2020-2034
  • Figure 20: Global mRNA Vaccine Market Value Share Analysis, by Private Hospitals & Clinics, 2023 and 2034
  • Figure 21: Global mRNA Vaccine Market Value (US$ Mn), by Others, 2020-2034
  • Figure 22: Global mRNA Vaccine Market Value Share Analysis, by Other, 2023 and 2034
  • Figure 23: Global mRNA Vaccine Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 24: Global mRNA Vaccine Market Share Analysis, by Region, 2023
  • Figure 25: Global mRNA Vaccine Market Share Analysis, by Region, 2034
  • Figure 26: Global mRNA Vaccine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 27: North America mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 28: North America mRNA Vaccine Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 29: North America mRNA Vaccine Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 30: North America mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 31: North America mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 32: North America mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 33: North America mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 34: Europe mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 35: Europe mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 37: Europe mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 38: Europe mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 39: Europe mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 40: Europe mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 41: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 42: Asia Pacific mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 43: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 44: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 45: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 46: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 47: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 48: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 49: Latin America mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 50: Latin America mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 51: Latin America mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 52: Latin America mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 53: Latin America mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 54: Latin America mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034
  • Figure 55: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 56: Middle East & Africa mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 58: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 59: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 60: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034
  • Figure 61: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034